The new complexity arising from the genome sequencing projects requires new comprehensive post-genomic strategies: advanced studies in regulatory mechanisms, application of new high-throughput technologies at a genome-wide scale, at the different levels of cellular complexity (genome, transcriptome, proteome and metabolome), efficient analysis of the results, and application of new bioinformatic methods in an integrative or systems biology perspective. This can be accomplished in studies with model organisms under controlled conditions. In this review a perspective of the favourable characteristics of yeast as a touchstone model in post-genomic research is presented. The state-of-the art, latest advances in the field and bottlenecks, new strategies, new regulatory mechanisms, applications (patents) and high-throughput technologies, most of them being developed and validated in yeast, are presented. The optimal characteristics of yeast as a well-defined system for comprehensive studies under controlled conditions makes it a perfect model to be used in integrative, 'systems biology' studies to get new insights into the mechanisms of regulation (regulatory networks) responsible of specific phenotypes under particular environmental conditions, to be applied to more complex organisms (e.g. plants, human).
Introduction
The completion of the first draft of the human genome sequence by the International Human Genome Mapping Consortium (2001a Consortium ( , 2001b has revealed a complex picture and confirmed that it was presumptuous to assume that once the sequence had been obtained all problems would be solved (Shoemaker et al., 2001; Levine and Tjian, 2003) . In fact, more questions have arisen which show that the complexity of biological systems lies not only in the basic units of information (or genes) contained in the genome (Morange, 2002; Dillon, 2003; Pearson, 2003) , but in the regulatory circuits which control the expression of these genes, synthesis of proteins and changes of internal metabolic pools which allow the cell to respond to environmental changes, mediated by specific sensing and regulatory mechanisms in an tightlycontrolled way (Oliver, 1996; Oliver et al., 1998; Kitano, 2002; Morange, 2002; Levine and Tjian, 2003; Tate and Cooper, 2003) . In spite of this, however, many studies continue to work on the discovery of genes responsible for specific diseases, while ignoring the influence of epigenetic factors and the environment (Morange, 2002; Levy-Lahad and Plon, 2003) .
The current 'genomic revolution' is generating large amounts of valuable information in the form of genome sequences. This new knowledge has to be accompanied by post-genomic studies based on new advanced methods, strategies and technologies which have to be continuously developed and improved. These methods and strategies should be mainly directed to the elucidation of the function of new genes, new mechanisms of regulation, and gene regulatory networks responsible for specific phenotypes at the different biological levels: genome, transcriptome, proteome and metabolome, in an integrative or systems biology perspective (Delneri et al., 2001; Kitano, 2002; Oliver, 2002; Oliver et al., 2002) . In this context, the exploitation of model organisms (Table 1) (Cech, 2001; Bahls et al., 2003 ) is central, not only to continued generation of basic knowledge on new regulatory mechanisms and cell biology, but also in the development of advanced techniques for the analysis of genomic information under controlled, reproducible conditions, which are difficult to apply to more complex organisms (e.g. plants and mammals) (Arabidopsis Genome Initiative, 2000; International Human Genome Mapping *To whom correspondence should be addressed. Consortium, 2001; Mouse Genome Sequencing Consortium, 2002) . Finally, the large volume of information generated (raw and processed data) has to be curated, stored and managed efficiently. For that purpose, robust bioinformatic tools, in the form of databases and methods for data mining, as well as the processing, analysis and dissemination of the information are necessary (Kell and King, 2000; Cornell et al., 2003; Doniger et al., 2003; Taylor et al., 2003) .
This review will present a perspective of the most recent developments in post-genomic studies. First, an overview of the last advances in basic knowledge and applied research at the genome, transcriptome, proteome and metabolome level is provided, with examples of studies in different organisms. Direct applications in the form of patents are also included. Based on this picture, a view of some overlooked features in post-genomic studies is presented. Particular emphasis is placed on the careful selection of the model organism, level of analysis, experimental design and controlled cultivation conditions in order to get reliable results, leading to valid conclusions. Finally, in the last part of the review attention is focused on the favourable characteristics of yeast as a model organism in postgenomic research. Examples of the most relevant scientific knowledge, methods and strategies developed in yeasts (Saccharomyces cerevisiae and Schizosaccharomyces pombe) are presented. The optimal characteristics of yeasts make them valuable tools for comprehensive studies at the genome, transcriptome, proteome and metabolome levels, and global integrative strategies. These aspects are discussed, together with their implications and future prospects for application in systems biology research.
Post-genomic Studies. Perspective. New Challenges
The generation of huge volumes of genomic sequences is revealing new complexity. For example, the analysis of the number of genes in the human genome, lower than initially expected (Pearson, 2003) has resulted in a new perspective in which the complexity of an organism is progressively being analysed not as a direct consequence of the number of genes, but on the basis of the control mechanisms responsible for regulation or 'tuning' of gene action and interaction. The concept of the gene as a physical unit of information has been under debate since its origin, and is currently being revisited (Morange, 2002; Dillon, 2003) . Moreover, the presence of a high proportion of non-coding sequences cannot be considered 'junk DNA' any more, but underlie important functions yet to be elucidated, as demonstrated by the fact that such sequences are significantly more conserved (80% to 90% the same on average across most of the species) than some protein-coding genes . As a consequence of this, the identity of other functional elements of the DNA sequence (promoters and transcriptional regulatory sequences) along with determinants of chromosome structure and function has to be established, and new initiatives are being directed to this objective (e.g. ENCODE project: ENCyclopedia Of DNA Elements. http:// www.genome.gov/10005107). The latest studies are providing new insights into the mechanisms of transcriptional regulation and gene silencing by RNA interference (RNAi) (Hannon, 2002; Schramke and Allshire, 2003; Volpe et al., 2003) and the small ubiquitin-related modifier (SUMO) family of et al.,1996, 1997) http://www.yeastgenome.org/ (Sz. pombe) (Wood et al., 2002) http://www.sanger.ac.uk/Projects/S_pombe/ proteins (Muratani and Tansey, 2003; Shiio and Eisenman, 2003; Verger et al., 2003) . This new complexity presents one of the main challenges in post-genomic studies.
The most advanced post-genomic strategies are directed to the elucidation of new genes, their function and mechanisms of regulation, using new techniques at different levels of study. Thus:
1) Strategies at the genome level. Having the completed sequence of an organism as a reference (e.g. Table 1 and references therein) new molecular techniques are being developed for identifying genes and functional elements. Thus, comparison of the sequences between closely and less related organisms is providing valuable information from the conserved and non-conserved sequences between species (Blaxter, 2003; Cliften et al., 2003; Dermitzakis et al., 2003; Guigo et al., 2003; Kellis et al., 2003) . Also, strategies for genome-wide analysis of disruption phenotypes, or generation of knockout mutants are being applied to different model organisms (e.g. yeast and the mouse, Ross-MacDonald et al., 1999; Winzeler et al., 1999; Warringer and Blomberg, 2003 ; Mouse knockout and mutation database: http://research. bmn.com/mkmd). In addition, new transcomplementation strategies are being developed to provide valuable information on the function of human genes .
2) Strategies at the gene expression (transcriptome) level. In the last decades, several methods have been developed for the analysis of messenger RNA, with the objective of comparing patterns of gene expression between cells or under different conditions (for more information, see Liang and Pardee, 2003) . However, the application of some of these techniques at a global, genome-wide, scale can be too onerous (Brown et al., 2001) . With the recent development of hybridisation-array technology (Schena et al., 1995; Lashkari et al., 1997; Wodicka et al., 1997; Gasch et al., 2000) , gene expression studies are increasingly being used for functional discovery, analysis and experimental annotation of reference genomes (Hughes et al., 2000; Shoemaker et al., 2001; Hayes et al., 2002; Bono et al., 2003; Levine and Tjian, 2003; Yamada et al., 2003) . Microarrays are also being applied in analyses of differential expression in cells and tissues, gene discovery, drug screening and diagnostics (US Patent 6544742; 2003124581; 2003180774; WO Patent 0218646) .
3) Post-transcriptional gene silencing strategies. Nucleicacid-based inhibitors of gene expression (antisense agents) have been used over the past 25 years. Among the more commons agents currently used are antisense oligonucleotides (ODNs), ribozymes, DNAzymes and RNA interference (RNAi) (Scherer and Rossi, 2003) . In the last few years, interest has focused on the capacity of double-stranded RNAs (dsRNAs) to target degradation of complementary sequences, referred as RNA interference (RNAi) (Hannon, 2002; Scherer and Rossi, 2003) . The exact mechanisms underlying these effects are the subject of current investigations Volpe et al., 2003) . However, despite the existence of possible limitations in the use of antisense agents in different organisms (Cho et al., 2001; Cho-Chung and Becker, 2003; Scherer et al., 2003) the fact that RNAi may elicit targeted specific knockdown of gene expression makes it a valuable tool for studying gene function (Elbashir et al., 2001; Kamath et al., 2003) . At this moment RNAi is an emerging field, and significant investments are being made in research and in the development of new applications (Howard, 2003; WO Patent 03070918; 03087371) . 4) Strategies at the proteome level. The study of the global set of a cell's proteins (the proteome) constitutes one of the most daunting challenges in biology. The most advanced studies are focused on new techniques for purification and analysis of proteins and protein phosphorylation sites (Rigaut et al., 1999; Brancia et al., 2001; Ficarro et al., 2002; Knight et al., 2003) , the study of protein-protein interactions and protein complexes (Uetz et al., 2000; Ito et al., 2001; Gavin et al., 2002; Ho et al., 2002; von Mering et al., 2002) and their subcellular localization (Ghaemmaghami et al., 2003; Wohlschlegel and Yates, 2003) . At the mechanistic level, the studies on how the ubiquitin-proteasome system, particularly the small ubiquitin-related modifier (SUMO) family of proteins controls transcription, and the mechanisms of protein turnover are also subject of increasing study (Pratt et al., 2002; Muratani and Tansey, 2003; Shiio and Eisenman, 2003; Verger et al., 2003) . Together with this, the comparison of proteomes between organisms is increasingly being used (Chervitz et al., 1998; Costanzo et al., 2000; Peri et al., 20003; Taylor et al., 2003) , with the objective of understanding the protein complexes and protein organization in human cells (Gavin and Superti-Furga, 2003) . Finally, in an important breakthrough in the field, the construction of protein microarrays containing a whole proteome on a chip (the yeast proteome) has recently been achieved (Zhu et al., 2001; . This technology, although not exempt from limitations and still subject to improvement (Kodadek, 2001; Mitchell, 2002; Cutler, 2003) opens the possibility of proteome-wide studies, global analyses of protein interactions or activities at a proteomic scale, with direct applications. At this moment, while new strategies and technologies are being studied to overcome the limitations (Ouyang et al., 2003) new applications, including analysis of antibody specificities, yeast protein activities and new antibody arrays, are being developed (Lal et al., 2002; Michaud et al., 2003; WO Patent 0194946; 02092118; 0239120; 03025213; .
5) Strategies at the metabolome level. The complete pool of cellular metabolites (the metabolome) comprises the whole range of molecules and intermediary metabolites subject to biochemical conversion through the tightly-regulated network of metabolic pathways, in order to generate energy and building blocks for growth and the maintenance of cellular functions. The concentrations and variations in the levels of metabolites directly reflect the metabolic state of the cell, and the metabolome is considered the closest level of analysis to the cell's phenotype (Trethewey et al., 1999; Raamsdonk et al., 2001; Adams, 2003) . Metabolic profiling of internal metabolites (metabolic fingerprinting) is currently being used in a wide variety of organisms (yeast, plants, mammalian cells) (Trethewey et al., 1999; Raamsdonk et al., 2001; Fiehn, 2002; Watkins and German, 2002; Castrillo et al., 2003) . The main current limitation at this point is the need for sensitive, high-throughput methods for extraction and global analysis of different families of metabolites, and for the screening of large numbers of samples Castrillo et al., 2003 and references therein) . In this context, metabolic profiling of metabolites extruded to the medium (metabolic footprinting) may constitute a complementary approach, and new studies are showing the validity of these strategies for specific purposes (e.g. classification of yeast mutants; Kell and Mendes, 2000; Allen et al., 2003) . Among the most advanced metabolome studies reported are new methods and strategies for metabolic profiling in plants and mammalian cells (Fiehn et al., 2000; Watkins and German, 2002) and metabolic control analysis and strategies for the elucidation of the function of new genes and metabolic pathways (Teusink et al., 1998; Raamsdonk et al., 2001; Trethewey, 2001; de la Fuente et al., 2002b; Weckwerth and Fiehn, 2002) . At the mechanistic level, the role of some amino acids and other specific metabolites in controlling gene expression has also being reported (Fafournoux et al., 2000; Hansen and Johannesen, 2000; So and Crowe, 2000) , which opens the field to new advanced studies. Finally, the analysis of the metabolome and use of metabolic profiling techniques has found direct applications in the investigation of molecules for evaluation of health and disease states (biomarkers) for application in diagnostics, and for the screening of new drugs (Griffin et al., 2001; Watkins and German, 2002 ; US Patent 2003180800; WO Patent 9957306; 0178652; 02057989). 6) Bioinformatic methods. The high volume of information generated at the different functional genomic levels has to be processed efficiently. Advanced bioinformatic strategies, databases, and management methods are progressively being implemented to cope with the requirements of the postgenomic era. The main tools can be summarized as follows: a) Methods and protocols for efficient extraction of genomic information (e.g. Minimum Information About a Microarray Experiment, MIAME, Brazma et al., 2001 Payne and Garrels, 1997; Costanzo et al., 2000; Peri et al., 2003) and biomolecular interaction databases (e.g. BIND, Bader et al., 2003;  http://www.blueprint.org/bind/bind.php); Metabolic pathways and metabolic databases, KEGG (http:// www.genome.ad.jp/kegg/); MetaFluxNet (Lee et al., 2003b) (see also later section, Table 2 ). c) Methods for data annotation and curation under community standards (e.g. Microarray Gene Expression Data standards, MGED, and Proteomics Standards Initiative, PSI; Brazma et al., 2001; Orchard et al., 2003; Hermjakob et al., in press;  http://www.mged.org/index.html; http://psidev. sourceforge.net).
d) Strategies for processing of data, normalization and statistical analysis (Fang et al., 2003; Tilstone, 2003) . e) Methods for advanced analysis of genomic data by applying multivariate analysis tools (chemometric methods; e.g. unsupervised or supervised methods, Kell and King, 2000; Bryant et al., 2001) for comparative studies of patterns of expression of internal relationships, and clustering analysis (i. e. gene networks, transcription factor networks, metabolic networks; de la Fuente et al., 2002a; Mendes, 2002; Wu et al., 2002; Fiehn and Weckwerth, 2003) .
f) Global management systems of genomic information at the different levels of study. GIMS (Cornell et al., 2003) ; MAPPFinder and geneMAPP (Doniger et al., 2003) . Part of these bioinformatic tools, data management and methods of analysis can be accessed freely (e.g. web resources with free access to all or some specific areas), or restricted to specific applications (e.g. bionformatic methods for specific studies on microarrays and analysis of metabolic profiles; EPO Patent 1300778; WO Patent 0140896).
Comprehensive Methods of Analysis Require Rigor in Experimental Design
The comprehensive scope and high-throughput nature of functional genomic analyses have caused understandable excitement in the research community. However the global character and speed of these analyses require investigators to take particular care in the design of experiments in order to remove confounding variables and obtain only data that are relevant to the biological questions being posed. Not all postgenomic analyses have shown sufficient rigor in experimental design and data analysis. Moreover, some of the methods applied in post-genomic studies are still in their first stages of development, and may need refinement and proper validation in touchstone models under controlled conditions (see next section). All of us need to be careful not to overlook these problems in our post-genomic studies. The most relevant problems include: a) Conceptual. Genes are defined by function and there are other functional elements in the DNA sequence besides the reading frames (Dillon, 2003; Pearson, 2003) . Some studies have shown discrepancies between mRNA abundance and protein content, or enzyme activity (Gygi et al., 1999; ter Kuile, 1999; Glanemann et al., 2003) . Thus, the existence of mechanisms or regulation at the post-transcriptional, posttranslational, and metabolic levels should not be ignored (Fafournoux et al., 2000; Hansen and Johannesen, 2000; So and Crowe, 2000; Muratani and Tansey, 2003; Schramke and Allshire, 2003; Verger et al., 2003; Volpe et al., 2003 In liquid cultures, there are also intrinsic factors that have to be taken into account. One of them is the existence of an intrinsic variability within a population of microbial cells, with cells growing at different growth rates, or being at different phases of their division cycles. The existence of this heterogeneity has led some authors to recommend the implementation of new strategies to undertake analyses at the 'single cell' level (Lidstrom and Meldrum, 2003) . However, multiple small-scale batch cultures (Lasko et al., 2000;  (Lee et al., 2003b) http://mbel.kaist.ac.kr/mfn/ KEGG http://www.genome.ad.jp/kegg/ Genome Information Management System (GIMS) (Cornell et al., 2003) http://www.cs.man.ac.uk/img/gims/ Warringer and Blomberg, 2003) , and other systems strategies, such as continuous culture systems (Castrillo and Ugalde, 1994; Weusthuis et al., 1994; Lane et al., 1999; ter Linde et al., 1999) , competition experiments Giaever et al., 2002) and synchronization of cultures for cell cycle studies (Spellman et al., 1998; Walker, 1999; Muller et al., 2003) are extensively used.
The new high-throughput methods of post-genomic analysis at the levels of transcriptome, proteome and metabolome present the possibility of generating comprehensive sets of data. However, the considerable cost of these systems (e.g. microarrays) may limit the number of experiments that can be performed. A careful selection of the objectives, including a decision about if statistical analysis needs to be included, has to be the highest priority. In some cases, the high cost can make it tempting to reduce the number of replicate experiments or analyses. However, this can compromise the interpretation of the results, if good reproducibility, accuracy, and a proper statistical treatment are necessary (Hayes et al., 2002; Tilstone, 2003) . c) In the technological context, finally, some sources of variability and limitations are still present in studies of geneexpression data (microarrays for transcriptome studies) (Grunenfelder and Winzeler, 2002; Spruill et al., 2002) , and appropriate strategies, controlled conditions and quality control methods are strongly recommended (Hayes et al., 2002; US Patent 2003170672) . Existence of possible nonsequence specific effects in antisense RNAs strategies has also been described (Cho et al., 2001; Cho-Chung and Becker, 2003; Kamath et al., 2003) . Some limitations in proteinprotein interaction studies (von Mering et al., 2002) and protein microarrays (Kodadek, 2001; Mitchell, 2002) have also been reported, and new methods for analysis of a wider range of families of metabolites are under study (Castrillo et al., 2003) .
Finally, in the context of bioinformatic studies, there is a general consensus on the necessity for application of uniform methods under international standards (e.g. MIAME and Proteomics Standards Initiative, PSI; PEDRo, Brazma et al., 2001 , Orchard et al., 2003 Taylor et al., 2003 ; http:// www.mged.org/miame; http://psidev.sourceforge.net; http:// pedro.man.ac.uk/home.shtml) and the adoption of new strategies for proper filtering and curation of the data. All of this suggests that it is prudent to employ a number of independent analytical techniques in functional genomic studies (e.g. in transcriptome studies, microarray analysis combined with Northern, quantitative real-time PCR or differential display; Brown et al., 2001; Levine and Tjian, 2003) . The congruence of results between independent analyses or between different strategic approaches (e.g. transcriptome and metabolome; Urbanczyk-Wochniak et al., 2003) will permit a truly integrative perspective (see last section of the review) and may constitute the most useful approach to obtain reliable conclusions in post-genomic studies.
Yeast as a 'Touchstone' Model in Post-genomic Research
Saccharomyces cerevisiae exhibits a number of favourable characteristics, which have made it an optimal system for genetic, molecular and physiological studies. The most relevant are: simple methods of cultivation under controlled conditions, well characterized genetics and facile techniques of genetic manipulation. Many basic cellular mechanisms and biochemical processes were first elucidated in yeast, and a wide knowledge of the genetics, biochemistry and physiology of this yeast is presently available (Rose and Harrison, 1987-1995) .
Together with this, S. cerevisiae was the first eukaryotic organism for which the whole genome sequence was completed (Goffeau et al., 1996) . The knowledge of the sequence, combined with the existence of a comprehensive collection of gene deletion mutants (http://www.unifrankfurt.de/fb15/mikro/euroscarf/complete.html), and new high-throughput technologies for global analyses at a genomewide scale are rapidly extending the range of applications. Yeast is being increasingly used as a model organism in postgenomic studies. As an example of this, the performance of the majority of new genome-wide methods are first validated in yeast, using well-controlled reproducible conditions. To exemplify this, the most relevant methods and post-genomic strategies investigated using yeast as a model system are summarized here: a) At the level of the genome, the utilization of genetic methods, gene disruption and construction of a collection of deletion mutants for functional profiling and characterization (Ross-MacDonald et al., 1999; Winzeler et al., 1999; Giaever et al., 2002) , together with new methods of gene transcomplementation between human cells and yeasts, for the elucidation of the function of human genes . b) At the gene expression (transcriptome) level, yeast microarrays are used extensively (Lashkari et al., 1997; Wodicka et al., 1997; Spellman et al., 1998; Hayes et al., 2002) . In this field, transcriptional responses and patterns of expression of yeast under carefully controlled conditions (e.g. chemostat culture) are progressively being studied (ter Linde et al., 1999; Hayes et al., 2002; Boer et al, 2003; Lim et al., 2003) . c) At the proteome level. The first whole-proteome microarray has been developed in yeast (Mitchell, 2002; Michaud et al., 2003; as well as new strategies for the preparation of proteins arrays (Washburn, 2003) . The first studies, reported in yeast, on subcellular localization of proteins on a proteome-wide scale (Ghaemmaghami et al., 2003; Huh et al., 2003) , phosphoproteome analysis (Ficarro et al., 2002; Knight et al., 2003) and protein-protein interaction maps (Uetz et al., 2000; Ito et al., 2001; Gavin et al., 2002; Ho et al., 2002) . Also, a new strategy for the investigation of enzymatic activities associated to specific metabolic pathways has been recently reported , as well as the role of posttranslational effects (protein turnover) as an overlooked dimension in proteomics (Pratt et al., 2002) . d) At the metabolome level. New methods for analysis of yeast metabolites (Castrillo et al., 2003) , strategies to ascribe function to unknown genes (Raamsdonk et al., 2001 ) and classification of yeast mutants using metabolic footprinting (Allen et al., 2003) . e) Some of the best examples may be found at the metabolic control and bioinformatic level, such as the development of new machine learning methods for the analysis of transcriptome, proteome and metabolome data and for the study of regulatory networks (Kell and Mendes, 2000; de la Fuente et al., 2002a; Mendes, 2002; Fiehn and Weckwerth, 2003) . Many of these advanced resources were first conceived for use in yeast (Payne and Garrels, 1997; Cornell et al., 2003) . A summary of the most relevant resources, databases and methods for global analysis of yeast genomic data is presented in Table 2 .
, In summary, the simplest eukaryote, S. cerevisiae, has been used extensively as a reference model in the past, in the elucidation of the fundamental molecular biology and biochemistry of the eukaryotic cell (Rose and Harrison, 1987-1995) . The optimal characteristics of this organism, its potential and validity in genome-wide studies at the different cellular levels (genome, transcriptome, proteome and metabolome) under controlled conditions, makes it an optimum model, both for the implementation of new advanced strategies and for the study of new mechanisms of regulation at the different levels of cellular complexity. Yeast is being used presently as a model organism to study the cell cycle and checkpoints (Gould and Nurse, 1989; Hartwell and Weinert, 1989; Spellman et al., 1998) ; cell polarity (Chang and Peter, 2003) ; mechanisms of evolution and speciation ; ageing and extension of lifespan (Howitz et al., 2003) ; mechanisms of infection and propagation of prions (Fernandez-Bellot and Cullin, 2001; Bach et al., 2003; Kryndushkin et al., 2003; Sherman and Muchowski, 2003) , and as a model to gain insight into the molecular pathology of neurodegenerative diseases (Outeiro and Lindsquit, 2003; Willingham et al., 2003) .
With this perspective, yeast is expected to continue providing new knowledge and insights in cell biology, as a relevant touchstone in the post-genomic era. In order to reach this goal, integrative studies are necessary, combining relevant information obtained from a single organism at the different functional genomic levels. In this context, yeast researchers are in a privileged position, offering them an excellent opportunity to employ new comprehensive integrative studies, whose knowledge can be related to information from other organisms, towards the objective of a better understanding of the cell biology of more complex systems (e.g. fly, plants, mouse, and human).
New Integrative Studies: Towards Systems Biology
The high volumes of complex data being generated in functional genomics studies may make the analysis and interpretation of results difficult and recommends the use of more comprehensive integrative studies in the post-genomic era (Delneri et al., 2001; Oliver et al., 2002; Phelps et al., 2002; Urbanczyk-Wochniak et al., 2003; WO Patent 03058238 In the case of yeast, its favourable characteristics make it an optimum platform for integrative studies. Relevant examples are the integrated approaches to identify previously overlooked genes (Kumar et al., 2002) and the studies of the hierarchical organization of transcriptome and metabolome networks in S. cerevisiae (ter Kuile and Westerhoff, 2001; Ihmels et al., in press ). These, and other studies already referred in this review, illustrate the huge potential of yeast as a touchstone model for integrative studies in the post genomics era (Oliver, 1997 (Oliver, , 1998 Oliver et al., 1998; Delneri and Oliver, 2000; Delneri et al., 2001) .
Conclusions. Future Perspectives
The initial excitement that the completion of the human genome sequence generated, not only among scientists but also among the general public, was based mainly on the new information and the huge possibilities that this knowledge could provide. Despite, or perhaps because, the human genome contained fewer genes than expected, the task of determining how these genes act and interact to build a human being remains a daunting one.
Even the complete solution of gene action and interaction to determine the workings of a yeast cell is a major challenge. A comprehensive and integrative approach is required, first studying the yeast cell at the different levels of complexity (genome, transcriptome, proteome and metabolome) and the regulatory networks of each level and their interrelation in the global system, using advanced bioinformatic methods and strategies towards the understanding of the cellular system as a global entity. Fortunately, the yeast Saccharomyces cerevisiae, as the first eukaryote to have its genome sequenced, is a superb 'touchstone' for post-genomic studies, and constitutes the best system in which to develop the required integrative or systems biology approach. These techniques and conceptual approaches developed with yeast, and the information obtained, will be invaluable in the analysis of progressively more complex organisms. 
